Cambridge Investment Research Advisors, Inc. Abiomed Inc Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 17, 2022	SELL	$242.49 - $301.46 $4,364 - $5,426	-18 Reduced 1.84%	960 $235,000
Q2 2022 Jul 13, 2022	BUY	$224.73 - $338.64 $15,281 - $23,027	68 Added 7.47%	978 $242,000
Q1 2022 May 12, 2022	BUY	$277.25 - $366.29 $18,298 - $24,175	66 Added 7.82%	910 $301,000
Q4 2021 Feb 03, 2022	SELL	$300.63 - $371.35 $8,417 - $10,397	-28 Reduced 3.21%	844 $303,000
Q3 2021 Nov 02, 2021	SELL	$310.19 - $376.2 $4,963 - $6,019	-16 Reduced 1.8%	872 $283,000
Q2 2021 Aug 10, 2021	SELL	$262.71 - $351.17 $88,007 - $117,641	-335 Reduced 27.39%	888 $277,000
Q1 2021 May 07, 2021	SELL	$285.92 - $355.13 $26,304 - $32,671	-92 Reduced 7.0%	1,223 $389,000
Q4 2020 Feb 04, 2021	SELL	$251.88 - $324.2 $3.43 Million - $4.42 Million	-13,637 Reduced 91.21%	1,315 $426,000
Q3 2020 Oct 29, 2020	BUY	$255.22 - $317.0 $3.42 Million - $4.25 Million	13,403 Added 865.27%	14,952 $4.14 Million
Q2 2020 Jul 27, 2020	BUY	$141.4 - $257.09 $3,110 - $5,655	22 Added 1.44%	1,549 $374,000
Q1 2020 May 08, 2020	SELL	$130.51 - $196.01 $73,868 - $110,941	-566 Reduced 27.04%	1,527 $221,000
Q4 2019 Feb 04, 2020	BUY	$159.31 - $223.54 $20,550 - $28,836	129 Added 6.57%	2,093 $357,000
Q3 2019 Nov 06, 2019	BUY	$175.89 - $279.23 $36,585 - $58,079	208 Added 11.85%	1,964 $349,000
Q2 2019 Aug 15, 2019	BUY	$250.96 - $284.94 $27,605 - $31,343	110 Added 6.68%	1,756 $0
Q1 2019 May 08, 2019	BUY	$276.39 - $362.25 $53,066 - $69,552	192 Added 13.2%	1,646 $0
Q4 2018 Feb 05, 2019	SELL	$281.08 - $444.25 $2.34 Million - $3.7 Million	-8,327 Reduced 85.13%	1,454 $472,000
Q3 2018 Nov 02, 2018	BUY	$354.53 - $449.75 $227,608 - $288,739	642 Added 7.02%	9,781 $0
Q2 2018 Aug 10, 2018	BUY	$278.07 - $446.21 $40,598 - $65,146	146 Added 1.62%	9,139 $0
Q1 2018 May 09, 2018	BUY	$192.49 - $295.85 $39,652 - $60,945	206 Added 2.34%	8,993 $0
Q4 2017 Feb 22, 2018	SELL	$168.78 - $199.74 $48,777 - $57,724	-289 Reduced 3.18%	8,787 $0
Q3 2017 Nov 07, 2017	BUY	$145.39 - $168.6 $1.32 Million - $1.53 Million	9,076	9,076 $1.53 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account